Skip to main content

Neal Edward Ready

Professor of Medicine
Medicine, Medical Oncology
Duke Box 3198, RM25178 Morris Bldg/ 200 Trent Dr., Durham, NC 27710
25178 Morris Bldg-200 Trent Dr., Box 3198, Durham, NC 27710

Current Appointments & Affiliations


Professor of Medicine · 2021 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2006 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.

Journal Article J Immunother Cancer · February 4, 2025 BACKGROUND: Our study was designed to determine the safety, efficacy, and immunological effects of perioperative pembrolizumab in early-stage NSCLC. METHODS: This is a single-arm phase II study of perioperative pembrolizumab in patients with untreated, cli ... Full text Link to item Cite

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

Journal Article Nat Commun · January 2, 2025 GT103 is a first-in-class, fully human, IgG3 monoclonal antibody targeting complement factor H that kills tumor cells and promotes anti-cancer immunity in preclinical models. We conducted a first-in-human phase 1b study dose escalation trial of GT103 in re ... Full text Open Access Link to item Cite
View All Publications

Recent Grants


DS7300-127 HAB08860

Clinical TrialPrincipal Investigator · Awarded by Daiichi Sankyo Inc · 2022 - 2027

BMS 050

Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2021 - 2026

View All Grants

Education, Training & Certifications


Vanderbilt University · 1986 M.D.
University of California, Irvine · 1983 Ph.D.